NDC 70710-1907-01 - Hydrocortisone sodium succinate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1907
- Requested NDC
- 70710-1907-01
- Package NDCs from labels
- 70710-1907-1, 70710-1907-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2026-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCORTISONE - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2026-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1907-1 | Hydrocortisone sodium succinate | 1 in 1 CARTON | INJECTION | 1 | 1 | |
| 70710-1907-1 | Hydrocortisone sodium succinate | 2 mL in 1 VIAL | INJECTION | 2 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Monobasic Sodium Phosphate and Dibasic Sodium Phosphate | MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE | Lupin Pharmaceuticals,Inc. | e2fcc382-6fac-4438-ad02-ebc8528dd59a | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 22ADO53M6F |
| K-Phos No. 2 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | Beach Products, Inc. | 9f446400-c403-4971-879e-1341f7f7d9da | 2023-02-23 | Adverse reactions | KH7I04HPUU |
| K Phos Neutral | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Beach Products, Inc. | 83376725-ee0f-40ad-bd90-31a61b9445cf | 2023-02-23 | Adverse reactions | 22ADO53M6F |
| NAT. PHOS. | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | Hyland's Inc. | 9ad86f9f-df9e-4e5c-bce4-571e1da44145 | 2022-12-19 | Warnings | 22ADO53M6F |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | Fresenius Kabi USA, LLC | 5bf47be3-f3fe-452b-8113-941796498345 | 2022-03-31 | Warnings, Adverse reactions | 22ADO53M6F |
| Sodium Phosphates | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Fresenius Kabi USA, LLC | e6169d3b-39d2-47f9-8d5b-b53ec069a722 | 2021-07-23 | Warnings, Adverse reactions | 22ADO53M6F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.